Keyword: Médecins Sans Frontières
Here is some other vaccine news of note for the week.
MSF's strong opposition didn't stop India's government from granting Pfizer a patent that protects Prevnar's exclusivity till 2026.
Congolese officials have given initial approval to the use of Merck’s as-yet-unlicensed Ebola shot to combat a local outbreak.
Health officials are in talks to deploy Merck & Co.’s experimental Ebola vaccine against a new outbreak in Congo.
MSF is taking an early step to mobilize Pfizer and GSK shareholders in its price-fighting effort by holding a “hackathon" in New York.